501 related articles for article (PubMed ID: 21486976)
1. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.
Launay O; van der Vliet D; Rosenberg AR; Michel ML; Piroth L; Rey D; Colin de Verdière N; Slama L; Martin K; Lortholary O; Carrat F;
JAMA; 2011 Apr; 305(14):1432-40. PubMed ID: 21486976
[TBL] [Abstract][Full Text] [Related]
2. Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial.
Launay O; Rosenberg AR; Rey D; Pouget N; Michel ML; Reynes J; Neau D; Raffi F; Piroth L; Carrat F;
JAMA Intern Med; 2016 May; 176(5):603-10. PubMed ID: 27064975
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial.
Rey D; Piroth L; Wendling MJ; Miailhes P; Michel ML; Dufour C; Haour G; Sogni P; Rohel A; Ajana F; Billaud E; Molina JM; Launay O; Carrat F;
Lancet Infect Dis; 2015 Nov; 15(11):1283-91. PubMed ID: 26257021
[TBL] [Abstract][Full Text] [Related]
4. Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults.
Potsch DV; Camacho LA; Tuboi S; Villar LM; Miguel JC; Ginuíno C; Silva EF; Mendonça RM; Moreira RB; Barroso PF
Vaccine; 2012 Sep; 30(41):5973-7. PubMed ID: 22828589
[TBL] [Abstract][Full Text] [Related]
5. Higher rate of long-term serologic response of four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: 4-year follow-up of a randomised controlled trial.
Chaiwarith R; Praparattanapan J; Kotarathititum W; Wipasa J; Chaiklang K; Supparatpinyo K
AIDS Res Ther; 2019 Nov; 16(1):33. PubMed ID: 31711528
[TBL] [Abstract][Full Text] [Related]
6. Comparative Efficacy of a High-Dose vs Standard-Dose Hepatitis B Revaccination Schedule Among Patients With HIV: A Randomized Clinical Trial.
Vargas JI; Jensen D; Martínez F; Sarmiento V; Peirano F; Acuña P; Provoste F; Bustos V; Cornejo F; Fuster A; Acuña M; Fuster F; Soto S; Estay D; Jensen W; Ahumada R; Arab JP; Soza A; Fuster F
JAMA Netw Open; 2021 Aug; 4(8):e2120929. PubMed ID: 34424307
[TBL] [Abstract][Full Text] [Related]
7. Randomized study of intradermal compared to intramuscular hepatitis B vaccination in HIV-infected children without severe immunosuppression.
Bunupuradah T; Ananworanich J; Pancharoen C; Petoumenos K; Prasitsuebsai W; Wongngam W; Ubolyam S; Sriheara C; Lange J; Phanuphak P; Puthanakit T
Vaccine; 2011 Apr; 29(16):2962-7. PubMed ID: 21329776
[TBL] [Abstract][Full Text] [Related]
8. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of low dose intradermal hepatitis B vaccine: results of a randomized trial among health care workers.
Das HS; Sawant P; Shirhatti RG; Vyas K; Vispute S; Dhadphale S; Patrawalla V; Desai N
Trop Gastroenterol; 2002; 23(3):120-1. PubMed ID: 12693152
[TBL] [Abstract][Full Text] [Related]
10. Comparison of immunogenicity and safety of four doses and four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: a randomized, controlled trial.
Chaiklang K; Wipasa J; Chaiwarith R; Praparattanapan J; Supparatpinyo K
PLoS One; 2013; 8(11):e80409. PubMed ID: 24265819
[TBL] [Abstract][Full Text] [Related]
11. Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination.
Barraclough KA; Wiggins KJ; Hawley CM; van Eps CL; Mudge DW; Johnson DW; Whitby M; Carpenter S; Playford EG
Am J Kidney Dis; 2009 Jul; 54(1):95-103. PubMed ID: 19481320
[TBL] [Abstract][Full Text] [Related]
12. Vaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Study.
Piroth L; Launay O; Michel ML; Bourredjem A; Miailhes P; Ajana F; Chirouze C; Zucman D; Wendling MJ; Nazzal D; Carrat F; Rey D; Binquet C;
J Infect Dis; 2016 Jun; 213(11):1735-42. PubMed ID: 26768256
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and safety of 4 vs. 3 standard doses of HBV vaccination in HIV-infected adults with isolated anti-HBc antibody.
Laksananun N; Praparattanapan J; Kotarathititum W; Supparatpinyo K; Chaiwarith R
AIDS Res Ther; 2019 May; 16(1):10. PubMed ID: 31053142
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and long-term durability of intradermal recombinant hepatitis B virus vaccine among intramuscular vaccine nonresponders: A prospective study in healthcare personnel.
Kalchiem-Dekel O; Grupel D; Bouchnik L; Sikuler E; Ben-Yakov G
J Gastroenterol Hepatol; 2015 Dec; 30(12):1782-7. PubMed ID: 26101816
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of a high-dose hepatitis B vaccine among patients receiving methadone maintenance treatment: A randomized, double-blinded, parallel-controlled trial.
Shi J; Feng Y; Gao L; Feng D; Yao T; Shi S; Zhang Y; Liang X; Wang S
Vaccine; 2017 Apr; 35(18):2443-2448. PubMed ID: 28343774
[TBL] [Abstract][Full Text] [Related]
16. A randomised controlled trial of intradermal hepatitis B vaccination and augmentation of response with erythropoietin.
Anandh U; Thomas PP; Shastry JC; Jacob CK
J Assoc Physicians India; 2000 Nov; 48(11):1061-3. PubMed ID: 11310381
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients.
Gilbert CL; Stek JE; Villa G; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
Vaccine; 2014 Nov; 32(48):6521-6. PubMed ID: 25252192
[TBL] [Abstract][Full Text] [Related]
18. Comparative immunogenicity of hepatitis B vaccine with different dosages and schedules in healthy young adults in China.
Wang ZZ; Li MQ; Wang P; Yang ZX; Wei L; Zeng Y; Li YP; Yan L; Liu XE; Zhuang H
Vaccine; 2016 Feb; 34(8):1034-9. PubMed ID: 26801063
[TBL] [Abstract][Full Text] [Related]
19. High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects.
Potsch DV; Oliveira ML; Ginuíno C; Miguel JC; Oliveira SA; Silva EF; Moreira RB; Cruz GV; Oliveira AL; Camacho LA; Barroso PF
Vaccine; 2010 Feb; 28(6):1447-50. PubMed ID: 19995540
[TBL] [Abstract][Full Text] [Related]
20. Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load.
Rey D; Krantz V; Partisani M; Schmitt MP; Meyer P; Libbrecht E; Wendling MJ; Vetter D; Nicolle M; Kempf-Durepaire G; Lang JM
Vaccine; 2000 Jan; 18(13):1161-5. PubMed ID: 10649616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
